| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2015 | US20150038551 Pharmaceutical Composition for Preventing or Treating Diabetes Containing TENC1 Expression or Activity Suppressor |
| 02/05/2015 | US20150038550 Targeting MicroRNAs for Metabolic Disorders |
| 02/05/2015 | US20150038547 Biological Basis of Adult Wellness |
| 02/05/2015 | US20150038544 Animal feed composition |
| 02/05/2015 | US20150038543 Anti-glycation properties of oxindole derivatives |
| 02/05/2015 | US20150038542 Uses of selective inhibitors of hdac8 and treatment of inflammatory conditions |
| 02/05/2015 | US20150038541 Composition and methods for cell modulation |
| 02/05/2015 | US20150038540 Instantly wettable oral film dosage form without surfactant or polyalcohol |
| 02/05/2015 | US20150038539 Method of increasing the extent of absorption of tizanidine |
| 02/05/2015 | US20150038537 Agents For The Control Of Parasites On Animals |
| 02/05/2015 | US20150038533 Phacetoperane for the treatment of attention-deficit hyperactivity disorder |
| 02/05/2015 | US20150038532 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral Administration |
| 02/05/2015 | US20150038530 Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage |
| 02/05/2015 | US20150038527 Furopyridine derivatives |
| 02/05/2015 | US20150038524 Crystalline naloxol-peg conjugate |
| 02/05/2015 | US20150038522 Combined anticancer drug sensitivity-determining marker |
| 02/05/2015 | US20150038520 Molecular Biomarkers for Predicting Response to Tyrosine Kinase Inhibitors in Lung Cancer |
| 02/05/2015 | US20150038519 Organic compounds |
| 02/05/2015 | US20150038518 Methods for the treatment of solid tumors |
| 02/05/2015 | US20150038513 Association between n-hydroxy-4-benzamide and folfox |
| 02/05/2015 | US20150038511 Treatment of immune-related and inflammatory diseases |
| 02/05/2015 | US20150038510 Cinnoline derivatives |
| 02/05/2015 | US20150038509 Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy |
| 02/05/2015 | US20150038508 Treatment of lupus nephritis using laquinimod |
| 02/05/2015 | US20150038500 Pharmaceutical composition for preventing and treating ophthalmic disorders |
| 02/05/2015 | US20150038499 Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
| 02/05/2015 | US20150038496 Methods and pharmaceutical compositions for the treatment of th2 mediated diseases |
| 02/05/2015 | US20150038495 Therapeutic agent for pain |
| 02/05/2015 | US20150038494 Thiazolopyrimidine Modulators as Immunosuppressive Agents |
| 02/05/2015 | US20150038491 Solid ivabradine-containing composition |
| 02/05/2015 | US20150038487 Methods of treating hypertrophic cardiomyopathy |
| 02/05/2015 | US20150038482 Isoxazole beta-lactamase inhibitors |
| 02/05/2015 | US20150038480 Compounds that modulate autoimmunity and methods of using the same |
| 02/05/2015 | US20150038479 Isoxazole beta-lactamase inhibitors |
| 02/05/2015 | US20150038478 Beta-lactamase inhibitors |
| 02/05/2015 | US20150038477 Orally administrable gallium compositions and methods of use |
| 02/05/2015 | US20150038476 Method for Treating Gynecological Diseases |
| 02/05/2015 | US20150038475 Testosterone undecanoate compositions |
| 02/05/2015 | US20150038474 Organic compounds |
| 02/05/2015 | US20150038473 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories |
| 02/05/2015 | US20150038472 Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids |
| 02/05/2015 | US20150038469 Compositions for treatment of cardiometabolic disorders |
| 02/05/2015 | US20150038468 Estrogen antagonists as treatments for sclerosing disorders |
| 02/05/2015 | US20150038467 Pharmaceutical compositions containing phosphatidylserine and curcumin |
| 02/05/2015 | US20150038464 Methods of increasing light responsiveness in a subject with retinal degeneration |
| 02/05/2015 | US20150038461 Thiopyrimidinecarboxamides as cxcr1/2 modulators |
| 02/05/2015 | US20150038459 Protein containing food stuffs |
| 02/05/2015 | US20150038458 Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof |
| 02/05/2015 | US20150038457 Composition comprising hyaluronic acid and mepivacaine |
| 02/05/2015 | US20150038456 Stable Hydrogel Compositions Including Additives |
| 02/05/2015 | US20150038454 Antimicrobial compositions and methods of use |
| 02/05/2015 | US20150038453 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 02/05/2015 | US20150038452 Methods of Treating Optic Disorders |
| 02/05/2015 | US20150038451 Substituted nucleotide analogs |
| 02/05/2015 | US20150038450 Combination therapy for the treatment of cancer |
| 02/05/2015 | US20150038449 Maintenance of Platelet Inhibition During Antiplatelet Therapy |
| 02/05/2015 | US20150038448 Combination, kit and method of reducing intraocular pressure |
| 02/05/2015 | US20150038447 Organ protection, preservation and recovery |
| 02/05/2015 | US20150038446 Compositions and methods for treating retinal degradation |
| 02/05/2015 | US20150038445 Methods and compositions for treating pain |
| 02/05/2015 | US20150038444 Treating myelodysplastic syndromes using lenalidomide |
| 02/05/2015 | US20150038443 Transcription Factor Inhibitors and Related Compositions, Formulations and Methods |
| 02/05/2015 | US20150038441 Kit-in-parts for cleaning and treating ears of companion animals |
| 02/05/2015 | US20150038440 Dihydrofuran azetidine derivatives as antiparasitic agents |
| 02/05/2015 | US20150038439 Method for preparing suspensions of low-solubility materials |
| 02/05/2015 | US20150038438 Antibacterial compounds and methods for use |
| 02/05/2015 | US20150038437 Antibacterial compounds and methods for use |
| 02/05/2015 | US20150038436 Tailored glycopolymers as anticoagulant heparin mimetics |
| 02/05/2015 | US20150038432 Compositions and methods for the treatment of retinal degeneration |
| 02/05/2015 | US20150038431 Inflammatory eye disorders |
| 02/05/2015 | US20150038429 Etoposide and doxorubicin conjugates for drug delivery |
| 02/05/2015 | US20150038425 Collagen-binding synthetic peptidoglycans for use in vascular intervention |
| 02/05/2015 | US20150038424 Formulations and kits for forming bioadhesive matrices |
| 02/05/2015 | US20150038416 Novel glp-1 receptor modulators |
| 02/05/2015 | US20150038412 Enhanced glycemic control using ad36e4orf1 and akt1 inhibitor |
| 02/05/2015 | US20150038409 Leptin Compositions and Methods for Treating Progressive Cognitive Function Disorders Resulting from Accumulation of Neurofibrillary Tangles and Amyloid Beta |
| 02/05/2015 | US20150038406 Pharmaceutical formulations of tranexamic acid and their use |
| 02/05/2015 | US20150037442 Composition to Enhance the Bioavailability of Curcumin |
| 02/05/2015 | US20150037438 Chewable gelled emulsions |
| 02/05/2015 | US20150037437 Glioma treatment |
| 02/05/2015 | US20150037427 Nano delivery systems |
| 02/05/2015 | US20150037426 Modified starch material of biocompatible hemostasis |
| 02/05/2015 | US20150037425 Powder compositions for inhalation |
| 02/05/2015 | US20150037424 Sustained release oral solid preparation |
| 02/05/2015 | US20150037423 Orally-disintegrating solid preparation |
| 02/05/2015 | US20150037419 Functional PLA-PEG Copolymers, the Nanoparticles Thereof, Their Preparation and Use for Targeted Drug Delivery and Imaging |
| 02/05/2015 | US20150037417 Morphine polymer release system |
| 02/05/2015 | US20150037415 Process for the preparation of a solid, orally administrable pharmaceutical composition |
| 02/05/2015 | US20150037414 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 02/05/2015 | US20150037413 Tamper resistant dosage forms |
| 02/05/2015 | US20150037412 Tamper resistant dosage forms |
| 02/05/2015 | US20150037411 Tamper resistant dosage forms |
| 02/05/2015 | US20150037410 Pharmaceutical compositions of ranolazine and dronedarone |
| 02/05/2015 | US20150037409 Controlled release hydrocodone formulations |
| 02/05/2015 | US20150037408 Delayed Release Pharmaceutical Compositions of Salsalate |
| 02/05/2015 | US20150037407 Method to improve the safety of handling of high potency drugs in solid dosage forms without changing their efficacy |
| 02/05/2015 | US20150037406 Novel crystalline form of sitagliptin sulfate |
| 02/05/2015 | US20150037405 Pharmaceutical compositions of levodopa and carbidopa |
| 02/05/2015 | US20150037401 siRNA Compositions and Methods for Inhibiting Gene Expression in Tumor Initiating Cells of breast Cancer |
| 02/05/2015 | US20150037400 Cytotoxic agents |